Zbigniew Gaciong

Author PubWeight™ 44.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010 5.46
2 Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med 2010 4.38
3 Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 2005 2.98
4 Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol 2007 1.92
5 Atorvastatin reduces sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolaemia and systemic arterial hypertension. Kardiol Pol 2009 1.48
6 Beneficial influence of carvedilol on urologic indices in patients with hypertension and benign prostatic hyperplasia: results of a randomized, crossover study. Urology 2013 1.42
7 Statins impair antitumor effects of rituximab by inducing conformational changes of CD20. PLoS Med 2008 1.26
8 Tonic activity of carotid body chemoreceptors contributes to the increased sympathetic drive in essential hypertension. Hypertens Res 2011 1.04
9 Cancer Screening in Unprovoked Venous Thromboembolism. N Engl J Med 2015 0.92
10 Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries. Transplantation 2002 0.90
11 Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis. Cardiovasc Res 2005 0.90
12 Statins impair glucose uptake in tumor cells. Neoplasia 2012 0.90
13 Influence of ACE I/D genotypes on left ventricular hypertrophy in aortic stenosis: gender-related differences. J Heart Valve Dis 2004 0.89
14 Simvastatin reduces sympathetic activity in men with hypertension and hypercholesterolemia. Hypertens Res 2010 0.88
15 Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey. Kardiol Pol 2013 0.87
16 A high red blood cell distribution width predicts failure of arteriovenous fistula. PLoS One 2012 0.85
17 The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation. Ann Transplant 2003 0.84
18 Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemp Clin Trials 2007 0.83
19 Urinary proteins, N-acetyl-β-D-glucosaminidase activity and estimated glomerular filtration rate in hypertensive patients with normoalbuminuria and microalbuminuria. Nephrology (Carlton) 2011 0.82
20 Pharmacological cardioversion of atrial fibrillation--a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously. Europace 2011 0.80
21 Arteriosclerosis in rat aortic allografts: dynamics of cell growth, apoptosis and expression of extracellular matrix proteins. Mol Cell Biochem 2003 0.80
22 Different diagnostic criteria significantly affect the rates of hypertension in 18-year-old high school students. Arch Med Sci 2010 0.80
23 Metabolism of collagen is altered in hypertensives with increased intima media thickness. Blood Press 2006 0.78
24 [Predictive value of plasma interleukin 1, interleukin 6, interleukin 8 and C-reactive protein (CRP) in patients with myocardial infarction]. Pol Arch Med Wewn 2003 0.78
25 Host-derived smooth muscle cells accumulate in cardiac allografts: role of inflammation and monocyte chemoattractant protein 1. PLoS One 2009 0.78
26 2015 guidelines for the management of hypertension. Recommendations of the Polish Society of Hypertension - short version. Kardiol Pol 2015 0.78
27 Liddle syndrome caused by P616R mutation of the epithelial sodium channel beta subunit. Pediatr Nephrol 2005 0.78
28 The effect of enalapril and telmisartan on clinical and biochemical indices of sympathetic activity in hypertensive patients. Clin Exp Hypertens 2008 0.77
29 Does the control of negative emotions influence blood pressure control and its variability? Blood Press 2014 0.77
30 SCORE model underestimates cardiovascular risk in hypertensive patients: results of the Polish Hypertension Registry. Blood Press 2011 0.77
31 [Erythromelalgia: two case reports and literature review]. Pol Arch Med Wewn 2007 0.76
32 [A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population]. Kardiol Pol 2015 0.76
33 Can angiotensin II +1675 G/A type 2 receptor gene polymorphism be a marker of left ventricular hypertrophy in patients with aortic stenosis? J Heart Valve Dis 2007 0.76
34 Analysis of PTEN mutation in non-familial pheochromocytoma. Ann N Y Acad Sci 2006 0.76
35 The effect of statins on sympathetic activity: a meta-analysis. Clin Auton Res 2015 0.76
36 Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey. Kardiol Pol 2016 0.75
37 [Influence of insertion-deletion polymorphism of the angiotensin converting enzyme gene on left ventricular hypertrophy in patients with aortic stenosis--differences in men and women]. Pol Arch Med Wewn 2002 0.75
38 [Awareness of the risks of hypertension in Poland: current status and ways to improve]. Kardiol Pol 2012 0.75
39 Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham Heart Study. Eur Heart J 2005 0.75
40 [Do adipocytokines cause hypertension?]. Kardiol Pol 2010 0.75
41 Laparoscopic treatment of adrenal cysts - own research and literature review. Endokrynol Pol 2015 0.75
42 [Assessment of renal arteries in patients suspected of having renovascular hypertension: comparison of Doppler sonography with multiphase MR angiography]. Przegl Lek 2004 0.75
43 Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland. J Appl Genet 2005 0.75
44 Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients: A meta-analysis. Cardiol J 2010 0.75
45 [Heart failure following lumbar surgery]. Pol Arch Med Wewn 2004 0.75
46 Pretransplant and early posttransplant predictors of chronic allograft nephropathy in cadaveric kidney allograft--a single-center analysis of 1112 cases. Transpl Int 2003 0.75
47 Resistant: hypertension, patient, or physician? Pol Arch Med Wewn 2015 0.75
48 Management of bleeding or urgent interventions in patients treated with direct oral anticoagulants (DOACs) - 2017 management proposals in Poland. Pol Arch Intern Med 2017 0.75
49 Catecholamine excretion and circadian blood pressure profile in patients with pheochromocytoma. Ann N Y Acad Sci 2006 0.75
50 Physicians and pharmaceutical industry. Ann Transplant 2002 0.75
51 [Alagille syndrome and chronic renal failure]. Pol Arch Med Wewn 2003 0.75
52 [Severe hypercholesterolaemia - when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement]. Kardiol Pol 2016 0.75